Cost-effectiveness of migraine therapy: Non-prescription analgesics vs a selective serotonin receptor agonist

被引：0

作者：

Goldstein, Jerome ^{[1
]}

Kruep, E. ^{[1
]}

机构：

[1] San Francisco Headache Clin, San Francisco, CA USA

来源：

CEPHALALGIA | 2007年 / 27卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

F130

引用

页码：1194 / 1194

页数：1

共 50 条

[1] Oral serotonin receptor agonistsA review of their cost effectiveness in migraine
Jennifer H. Lofland
David B. Nash
PharmacoEconomics, 2005, 23 : 259 - 274
[2] Oral serotonin receptor agonists - A review of their cost effectiveness in migraine
Lofland, JH
Nash, DB
PHARMACOECONOMICS, 2005, 23 (03) : 259 - 274
[3] Cost-effectiveness analysis of erenumab vs onabotulinumtoxinA for chronic migraine in Spain
Pozo-Rosich, Patricia
Poveda, Jose Luis
Sanchez, Sergio
Crespo, Carlos
Martinez, Maria
Irimia, Pablo
CEPHALALGIA, 2022, 42 (1_SUPPL) : 118 - 119
[4] COST-EFFECTIVENESS OF EARLY VS. NON-EARLY INTERVENTION IN ACUTE MIGRAINE WITH ALMOTRIPTAN IN SPAIN
Slof, J.
VALUE IN HEALTH, 2011, 14 (07) : A322 - A322
[5] Cost-effectiveness of cognitive behavioural therapy and selective serotonin reuptake inhibitors for major depression in children and adolescents
Haby, MM
Tonge, B
Littlefield, L
Carter, R
Vos, T
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2004, 38 (08): : 579 - 591
[6] COST-EFFECTIVENESS OF SELECTIVE SEROTONIN REUPTAKE INHIBITORS IN THE TREATMENT OF MAJOR DEPRESSION IN MEXICO
Idrovo, J.
Rivas, R.
Zapata, L.
VALUE IN HEALTH, 2009, 12 (07) : A487 - A487
[7] COST-EFFECTIVENESS COMPARISON OF OPOID SUBSTITUTION THERAPY VS. NON-PHARMCOLOGIC THERAPY IN THE STATE OF KUWAIT
Hren, R.
Milanic, M.
VALUE IN HEALTH, 2017, 20 (09) : A711 - A711
[8] FOCUS ON SUMATRIPTAN - A SELECTIVE SEROTONIN-1D RECEPTOR AGONIST FOR THE ACUTE TREATMENT OF MIGRAINE
FANKHAUSER, MP
WENDT, JK
HOSPITAL FORMULARY, 1993, 28 (03): : 247 - &
[9] Cost-effectiveness study of rizatriptan vs. usual care in the treatment of migraine in Canada
Desjardins, B
Thompson, M
Ferko, N
Marceau, C
Gawel, M
VALUE IN HEALTH, 2003, 6 (06) : 762 - 763
[10] COST-EFFECTIVENESS OF VAGINAL ESTROGEN AND SELECTIVE ESTROGEN RECEPTOR MODULATOR THERAPY VS. FRACTIONAL VAGINAL LASER FOR TREATMENT OF GENITOURINARY SYNDROME OF MENOPAUSE
Hesham, H.
James, K.
Mitchell, C.
INTERNATIONAL UROGYNECOLOGY JOURNAL, 2019, 30 : S235 - S236

← 1 2 3 4 5 →